Economic effects of an eradication protocol for first appearance of Pseudomonas aeruginosa in cystic fibrosis patients: 1995 vs. 2009

Journal of Cystic Fibrosis

Volumn 10, Issue 3, 2011, Pages 175-180

  Lillquist, Yolanda P ^a   Cho, Eva ^a   Davidson, A George F ^a  

^a BC CHILDREN S HOSPITAL   (Canada)

Author keywords

Antibiotics; Cost; Economic; Eradication; Hospitalization; Pseudomonas aeruginosa

Indexed keywords

CIPROFLOXACIN; COLISTIMETHATE; PIPERACILLIN; TOBRAMYCIN;

ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BURKHOLDERIA CEPACIA; CHILD; CYSTIC FIBROSIS; ECONOMIC ASPECT; HUMAN; INFANT; LUNG FUNCTION; MAJOR CLINICAL STUDY; NEWBORN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION;

ADMINISTRATION, ORAL; ADOLESCENT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BURKHOLDERIA CEPACIA COMPLEX; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; COHORT STUDIES; COLISTIN; CYSTIC FIBROSIS; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; INFANT; INJECTIONS, INTRAVENOUS; NEBULIZERS AND VAPORIZERS; PIPERACILLIN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TOBRAMYCIN; TREATMENT OUTCOME;

EID: 79955966945     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2011.01.002     Document Type: Article

References (19)

1. Ramsey B.W. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 1996, 335:179-188.
2. Hoiby N., Flensborg E.W., Beck B., Friis B., Jacobsen S.V., Jacobsen L. Pseudomonas aeruginosa infection in cystic fibrosis. Scan J Resp Dis 1997, 58:65-79.
3. Winnie G.B., Cowan R.G. Respiratory tract colonization with Pseudomonas aeruginosa in cystic fibrosis: correlation between Pseudomonas aeruginosa antibody levels and pulmonary function. Pediatr Pulm 1991, 10:92-100.
4. Kerem E., Corey M., Gold R., Levison H. Pulmonary functions and clinical course in patients with cystic fibrosis after pulmonary colonizatiion with Pseudomonas aeruginosa. J Pediatr 1990, 116:714-719.
5. Pamukcu A., Bush A., Buchdhl R. Effects of Pseudomonas aeruginosa colonization lung function and anthropometric variables in children with cystic fibrosis. Pediatr Pulm 1995, 19:10-15.
6. McCubbin M.M., Ahrens R., Kao S., Seidel G., Teresi M. Pseudomonas infection appears to precede the development of bronchiectasis on chest CT scan in young children with CF. Pediatr Pulm 1996, S13:299.
7. Littlewood J.M., Miller M.G., Ghoneim A.T., Ramsden C.H. Nebulized colomycin for early Pseudomonas colonization in cystic fibrosis. Lancet 1985, 1:865.
8. Valerius N.H., Koch C., Hoiby N. Prevention of chronic Pseudomonas aeruginosa colonization in cystic fibrosis by early treatment. Lancet 1991, 338:725-726.
9. Wieseman H.G., Steinkamp G., Ratjen F., et al. Placebo controlled double blind, randomized study of aerosolized tobramycin for early treatment of Pseudomonas aeruginosa colonization in patients with cystic fibrosis. Pediatr Pulm 1998, 25:88-92.
10. Frederiksen B., Koch C., Hoiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in Cystic Fibrosis. Pediatr Pulm 1996, 23:330-335.
11. Gibson R.L., Emerson J., McNamara S., Burns J.L., Rosenfeld M., Yunker A., et al. Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis. Am J Respir Crit Care Med 2003, 167:841-849.
12. Taccetti G., Campana S., Festini F., Mascherini M., Doring G. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients. Eur Respir J 2005, 26:458-461.
13. Ratjen F., Munck A., Kho P., Angyalosi G. Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial. Thorax 2010, 65:286-291. for the ELITE Study Group.
14. Prestidge C, Chilvers M, Davidson AGF, Cho E, McMahon V, White C. Renal function in a pediatric cystic fibrosis patients in the first decade of life. Pediatr Nephrol. Online First. 2011.
15. Doring G., Conway S.P., Heijerman H.G.M., Hodson M.E., Hoiby N., Smyth A., et al. Consensus statement: antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000, 16:740-767.
16. Lee T.W.R., Brownlee K.G., Conway S.P., Denton M., Littlewood J.M. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003, 2:29-34.
17. Canadian Cystic Fibrosis Patient Data Registry Report 2008, Canadian Cystic Fibrosis Foundation. Fig. 19: page 24.
18. Lillquist YP, Davidson AG, et al. Time to event analysis of efficacy of an early aggressive eradication protocol for first growth Pseudomonas aeruginosa in cystic fibrosis. Pediatr Pulmonol 2007; 42: S30, 21st NACFC; Abstract 307.
19. Lillquist YP, Davidson AGF, et al. Surveillance of respiratory cultures - effect of intensive "first growth" Pseudomonas aeruginosa treatment protocol on respiratory flora in cystic fibrosis patients - 7year experience. Pediatr Pulmonol 2002; 34: S24; 16th NACFC; Abstract 303.